Literature DB >> 17000702

Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.

Hung-Yu Chang1, Jen-Der Lin, Shuo-Chi Chou, Tzu-Chieh Chao, Chuen Hsueh.   

Abstract

BACKGROUND: The follicular variant of papillary thyroid carcinoma (FVPTC) presents with biological and morphological features similar to papillary thyroid carcinoma. Pre-operative diagnosis of FVPTC and its clinical course is important in identifying appropriate surgical procedures.
METHODS: This study enrolled 85 patients, 68 females (mean age 41.4+/-13.7 years) and 17 males (mean age 50.1+/-12.3 years) with papillary thyroid carcinomas diagnosed as FVPTC. From the patient database at Chang Gung Medical Center (CGMC), 170 pure papillary thyroid carcinoma cases and 85 with minimally invasive follicular thyroid carcinomas of gender- and age-matched patients were randomly selected as control groups. All patients were categorized into high- and low-risk groups according to AMES criteria.
RESULTS: Of the three groups, 7.1% (follicular), 11.8% (FVPTC) and 34.1% (pure papillary thyroid carcinoma) of patients presented with lymph node or soft tissue invasion (P=0.0001). Additionally, 29.4, 11.8 and 2.4% of patients with follicular carcinoma, FVPTC and pure papillary thyroid carcinoma, respectively, presented with distant metastases at the time of diagnosis. Of the 85 FVPTC cases, 75 underwent pre-operative fine needle aspiration cytology (FNAC) examination at CGMC. Only 11 cases were diagnosed pre-operatively with papillary thyroid carcinomas. Kaplan-Meier survival curves for these three groups demonstrated that follicular thyroid carcinoma had a prognosis worse than both papillary thyroid carcinomas.
CONCLUSIONS: Most FVPTC cases were diagnosed as follicular neoplasm via pre-operative FNAC. In this study, FVPTC patients had a high ratio of distant metastases, few lymph node metastases and soft tissue invasion. Aggressive treatment was indicated for the high-risk FVPTC patients.

Entities:  

Mesh:

Year:  2006        PMID: 17000702     DOI: 10.1093/jjco/hyl093

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  21 in total

1.  Classical and follicular variant papillary thyroid carcinoma: comparison of clinical, ultrasonographical, cytological, and histopathological features in 444 patients.

Authors:  Didem Ozdemir; Reyhan Ersoy; Neslihan Cuhaci; Dilek Arpaci; Eren P Ersoy; Birol Korukluoglu; Gulnur Guler; Bekir Cakir
Journal:  Endocr Pathol       Date:  2011-06       Impact factor: 3.943

2.  Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: A name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment.

Authors:  Lester Dr Thompson
Journal:  Mod Pathol       Date:  2016-04-22       Impact factor: 7.842

3.  Comparison of the clinicopathological behavior of the follicular variant of papillary thyroid carcinoma and classical papillary thyroid carcinoma: A systematic review and meta-analysis.

Authors:  Jing Yang; Yanping Gong; Shuping Yan; Qingquan Shi; Jingqiang Zhu; Zhihui Li; Qiang Chen; Rixiang Gong
Journal:  Mol Clin Oncol       Date:  2015-04-06

Review 4.  Macrofollicular variant of papillary thyroid carcinoma with extensive lymph node metastases.

Authors:  Min-kyung Yeo; Ja Seong Bae; Woo Jin Oh; Gyeong Sin Park; Chan Kwon Jung
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

5.  Increasing diagnosis of thyroid papillary carcinoma follicular variant in south-east Anatolian region: comparison of characteristics of classical papillary and follicular variant thyroid cancers.

Authors:  Sibel Ertek; Nuray Can Yılmaz; Arrigo F Cicero; Özgül Vurupalmaz; Ahu Senem Demiröz; Gürbüz Erdoğan
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

6.  Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.

Authors:  Jarosław Jendrzejewski; Sandya Liyanarachchi; Andrew Eiterman; Andrew Thomas; Huiling He; Rebecca Nagy; Leigha Senter; Krzysztof Sworczak; Albert de la Chapelle
Journal:  Int J Cancer       Date:  2018-12-03       Impact factor: 7.396

7.  Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.

Authors:  Xiao-Min Yu; David F Schneider; Glen Leverson; Herbert Chen; Rebecca S Sippel
Journal:  Thyroid       Date:  2013-09-11       Impact factor: 6.568

8.  Combined GSTM1 and GSTT1 null genotypes are associated with a lower risk of papillary thyroid cancer.

Authors:  M C Lemos; E Coutinho; L Gomes; F Carrilho; F Rodrigues; F J Regateiro; M Carvalheiro
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

9.  Distinguishing classical papillary thyroid microcancers from follicular-variant microcancers.

Authors:  Surbhi Singhal; Rebecca S Sippel; Herbert Chen; David F Schneider
Journal:  J Surg Res       Date:  2014-03-19       Impact factor: 2.192

10.  Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

Authors:  Xiaoguang Shi; Rengyun Liu; Fulvio Basolo; Riccardo Giannini; Xiaopei Shen; Di Teng; Haixia Guan; Zhongyan Shan; Weiping Teng; Thomas J Musholt; Khawla Al-Kuraya; Laura Fugazzola; Carla Colombo; Electron Kebebew; Barbara Jarzab; Agnieszka Czarniecka; Bela Bendlova; Vlasta Sykorova; Manuel Sobrinho-Simões; Paula Soares; Young Kee Shong; Tae Yong Kim; Sonia Cheng; Sylvia L Asa; David Viola; Rossella Elisei; Linwah Yip; Caterina Mian; Federica Vianello; Yangang Wang; Shihua Zhao; Gisele Oler; Janete M Cerutti; Efisio Puxeddu; Shen Qu; Qing Wei; Huixiong Xu; Christine J O'Neill; Mark S Sywak; Roderick Clifton-Bligh; Alfred K Lam; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Hongyu Yu; Giovanni Tallini; Elizabeth H Holt; Vasily Vasko; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2015-11-03       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.